Logo | Name | Σ | ||
---|---|---|---|---|
CIC Construisons dans un monde qui bouge. CIC is the fourth largest banking group in France, consisting of seven regional banks which operate across France through a network of 1,844 branches employing 24,000 staff. CIC's customer base includes 2.7 million retail clients. One in eleven self-employed professionals is a CIC group client and nearly one in three companies banks with CIC Group. Banque de détail, Banque de financement, Activités de marchés, Banque privée, Capital-développement, Crédit, Assurance, Mobile, Automobile, and Télésurveillance Sectors: Bank | 2054 | 920 | 1271 | |
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3486 | 2601 | 833 | |
BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: Biotechnology French Cluster Public business cluster | 404 | 159 | 309 | |
Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its … Sectors: Startup accelerator & VC | 721 | 384 | 261 | |
Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: French Cluster Public business cluster | 629 | 381 | 382 | |
Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: Biotechnology French Cluster Public business cluster | 448 | 254 | 261 | |
Eurobiomed [Automatic translation follows] The key partner of future leaders in health Eurobiomed is the competitiveness cluster of the health sector bringing together the Provence Alpes Côte d'Azur and Languedoc-Roussillon regions. Created on January 1, 2009, the Cluster was recognized as a very high-performing cluster following the audit carried out in 2012 by the state, the results are there in number and amounts of projects financed, growth in turnover, growth in exports, direct jobs created and maintained by member companies. The Eurobiomed territory constitutes a large European region of health, It is also ranked second nationally for the density of public … Sectors: Biotechnology French Cluster Public business cluster | 393 | 238 | 182 | |
Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: Biotechnology French Cluster Public business cluster | 313 | 124 | 205 | |
Genopole Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy Sectors: Biotechnology | 316 | 162 | 160 | |
France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: Biotechnology Startup accelerator & VC | 837 | 488 | 511 | |
Eiffel Investment Group Investing for a sustainable world Eiffel Investment Group is a third-party asset manager with ca €6 billion under management* with a focus on positive impact strategies and the financing of the ecological and energy transition. Eiffel Investment Group’s investor base consists of large institutional investors (insurance companies, mutual insurers, pension funds, banks, family offices, public investors, etc.) as well as retail investors via intermediated distribution. Backed by the Impala group founded by entrepreneur Jacques Veyrat, Eiffel Investment Group cultivates a strong industrial expertise, in particular in the field of the energy transition, but also in the life sciences, agri-food and … Sectors: Startup accelerator & VC | 216 | 132 | 98 | |
Réseau Entreprendre Alsace [Automatic translation follows] "To create jobs, let's create employers" André Mulliez Réseau Entreprendre supports new managers, creators or business buyers, at all stages of a company's life: at start-up, in the development phase, in periods of strong growth. Sectors: Startup accelerator & VC | 1583 | 609 | 834 | |
Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: Biotechnology Pharmaceutical | 1487 | 870 | 336 |